Pathway and differential gene expression analyses comparing patient-matched whole blood, cultured CTCs, and corresponding CDX models also highlighted the potential cancer-agnostic role for NF-κB, EMT, and TGFβ signaling pathways crucial to metastasis. This evidence concerns the gene NFKB1 and cancer.